CD8A and neoplasm: Intriguingly, for the tumor‐free mice that survived to 60 days after EG7‐OVA cell challenge (KK2DP7/OVA+anti‐PD‐1), the percentage of effector memory T cells (TEM) and central memory T cells (TCM) in the CD3+CD8+ T cells showed a significant increase compared with that in the control mice (Figure 7i).